peopleInnovationCareers RarePipelineCollaborationFinanceAdvance treatment
Hansa Biopharma
HNSA (, %) SEK
Hansa Biopharma
Evenemang

Investerarrelationer Kontakt

Investor relations

Evan Ballantyne

Chief Financial Officer

E-mail: IR@hansabiopharma.com